Trophozoites of Plasmodium Vivax

by

QUESTION

What should I take in this condition? After treatment I came to know that Rechocin should be taken for 6 months 2  weekly.

ANSWER

I am not sure I understand your question, but if you have been diagnosed with trophozoites of Plasmodium vivax in your blood, then you can be treated with normal anti-malarials (the World Health Organization recommends artemisinin-based combination therapies for first line treatment of uncomplicated malaria, but depending where you are, you might even just be able to take chloroquine), as these kill the blood stages of malaria. To prevent relapse, caused by hypnozoites dormant in the liver, you should talk to your doctor about the possibility of also taking a course of primaquine, which usually lasts 14 days. This drug is not suitable for people with G6DP deficiency, however, so you may need a test for this condition before you can take the treatment.

New Malaria Parasites

by

QUESTION

I heard researchers have found a new malaria parasite—what is the name?

ANSWER

New malaria parasites are found quite regularly—the parasite that causes malaria, Plasmodium, actually infects birds, reptiles, rodents and non-human primates like monkeys and apes as well as humans. As such, non-human forms of malaria are discovered relatively frequently in other species. For example, a few years ago, some researchers looked at malaria in apes in Central Africa, and found a new species in gorillas, which is so new it has not even been fully described to science yet, and so remains unnamed! It is thought to be very closely related to Plasmodium falciparum, which is the most dangerous type of malaria in humans. Also recently, two new species were observed in chimpanzees, also in Central Africa, and names P. billcollinsi and P. billbrayi.

Even in humans, new infections are sometimes observed. One which has gained a lot of recent attention is not a new species, but what seems to be increasing numbers of cases of a monkey type of malaria (called P. knowlesi) in humans. It is unclear whether this is due to changes within the parasite, or changes to the landscape which might be creating more favorable conditions for the transmission of this malaria to humans. It is even possible that this malaria has always infected humans, and so this is not a new development, but due to diagnostic issues, it was mistaken for other, human malaria species, such as P. vivax and/or P. malariae.

Doxycycline After Malaria Diagnosis

by

QUESTION

My daughter is 24 and in rural Uganda for 4 months. She has been diagnosed with malaria (plasmodium falciparum) and is taking treatment now. Treatment is 3 tablets of Neosidar tablets contain of sulfadoxine BP and of pyrimethamine followed tonight and for the next 3 days by 4 tablets of Lumarten in the morning and at bedtime with milk. Lumarten is a mix of artemether and lumefantrine. Her doctor in Entebbe recommended she should stop taking doxycycline: “the doxy is like a lock on the door, and now someone has broken the lock, so it’s better to treat the malaria as it comes (while still using nets, bug spray, long sleeves, etc. to avoid bites) rather than keep taking the doxy every day.”

Should she stop taking doxycycline and should she be taking the Lumarten with milk? Thank you very much.

ANSWER

I am not personally familiar with Lumarten, but these antimalarials are often taken with food. Of more concern is that she has been given a sulfadoxine-pyramethamine treatment—these are no longer recommended as first line treatment against malaria, and so she should just take the artemisinin-based combination therapy (artemether-lumefantrine is such a combination therapy).

In terms of the doxycycline, I do not understand the doctor’s advice. There is no harm in continuing to take doxycycline after having malaria, and in fact it might prevent re-infection! Of course this depends on how long she is still in Uganda for—the doxy must be taken for four weeks after leaving the malarial area, so if she is returning home soon, she should weigh up the continued preventive benefit against the inconvenience of a long continuation of taking the medication. In general, I don’t like the doctor’s attitude that your daughter should just accept continuing infections with malaria, and “treat them as they come.” It’s much better to use all available methods for prevention. One thing to consider is that dairy products inhibit the uptake of doxycycline, so if your daughter was also taking her doxy with milk (some doctors mistakenly advise this, to prevent stomach upsets when taking the medication), that might have been one reason why she still got infected.

Malaria in Summer

by

QUESTION

Does malaria only occur during summer season?

ANSWER

That depends on where you are. The transmission of malaria depends on the presence of the mosquitoes which are required to transmit the disease (they do this when they bite you).

Many kinds of mosquito transmit malaria, though all are of the genus Anopheles. These different species have different climatic requirements, but all lay their eggs in pools of stagnant water, and the larve likewise live in this stagnant water until they develop into adults. As such, malaria is only transmitted when there are suitable pools of standing, stagnant water available for mosquitoes to breed, and also when the temperature is suitable for mosquito development (optimum temperature for mosquitoes is 25-27 degrees C—the malaria parasite develops most rapidly around this temperature as well, though can survive in temperatures about ten degrees cooler as well).

In some regions of the world, this combination of conditions is only met in the summer time, which means that malaria transmission only occurs during this season. In other parts of the world, such as coastal West Africa, conditions are suitable for mosquito breeding and malaria development all year round, which means that malaria transmission occurs throughout the year.

How is Malaria Prevented?

by

QUESTION

What are the methods to prevent malaria?

ANSWER

Malaria prevention consists of a combination of mosquito avoidance measures and chemoprophylaxis. Although very efficacious, none of the recommended interventions are 100% effective.

Mosquito Avoidance Measures

  • Because of the nocturnal feeding habits of Anopheles mosquitoes, malaria transmission occurs primarily between dusk and dawn.
  • Contact with mosquitoes can be reduced by remaining in well-screened areas, using mosquito bed nets (preferably insecticide-treated nets), using a pyrethroid-containing flying-insect spray in living and sleeping areas during evening and nighttime hours, and wearing clothes that cover most of the body.
  • All travelers should use an effective mosquito repellent.
  • The most effective repellent against a wide range of vectors is DEET (N,N-diethylmetatoluamide), an ingredient in many commercially available insect repellents. The actual concentration of DEET varies widely among repellents. DEET formulations as high as 50% are recommended for both adults and children older than 2 months of age (see the Protection Against Mosquitoes, Ticks, and Other Insects and Arthropods section later in this chapter). DEET should be applied to the exposed parts of the skin when mosquitoes are likely to be present.
  • In addition to using a topical insect repellent, a permethrin-containing product may be applied to bed nets and clothing for additional protection against mosquitoes.

Chemoprophylaxis

  • All currently recommended primary chemoprophylaxis regimens involve taking a medicine before travel, during travel, and for a period of time after leaving the malaria endemic area. Beginning the drug before travel allows the antimalarial agent to be in the blood before the traveler is exposed to malaria parasites.
  • Presumptive antirelapse therapy (also known as terminal prophylaxis) uses a medication towards the end of the exposure period (or immediately thereafter) to prevent relapses or delayed-onset clinical presentations of malaria caused by hypnozoites (dormant liver stages) of P. vivax or P. ovale. Because most malarious areas of the world (except the Caribbean) have at least one species of relapsing malaria, travelers to these areas have some risk for acquiring either P. vivax or P. ovale, although the actual risk for an individual traveler is difficult to define. Presumptive anti-relapse therapy is generally indicated only for persons who have had prolonged exposure in malaria-endemic areas (e.g., missionaries, volunteers).
  • In choosing an appropriate chemoprophylactic regimen before travel, the traveler and the health-care provider should consider several factors. The travel itinerary should be reviewed in detail and compared with the information on where malaria transmission occurs within a given country (see the Malaria Risk Information and Prophylaxis, by Country, section later in this chapter) to determine whether the traveler will actually be traveling in a part of the country where malaria occurs and if significant antimalarial drug resistance has been reported in that location.
  • The resistance of P. falciparum to chloroquine has been confirmed in all areas with P. falciparum malaria except the Caribbean, Central America west of the Panama Canal, and some countries in the Middle East. In addition, resistance to sulfadoxine–pyrimethamine (e.g., Fansidar) is widespread in the Amazon River Basin area of South America, much of Southeast Asia, other parts of Asia, and in large parts of Africa. Resistance to mefloquine has been confirmed on the borders of Thailand with Burma (Myanmar) and Cambodia, in the western provinces of Cambodia, in the eastern states of Burma (Myanmar), on the border between Burma and China, along the borders of Laos and Burma, and the adjacent parts of the Thailand–Cambodia border, as well as in southern Vietnam.
  • Additional factors to consider are the patient’s other medical conditions, medications being taken (to assess potential drug–drug interactions), the cost of the medicines, and the potential side effects.
      The medications recommended for chemoprophylaxis of malaria may also be available at overseas destinations. However, combinations of these medications and additional drugs that are not recommended may be commonly prescribed and used in other countries. Travelers should be strongly discouraged from obtaining chemoprophylactic medications while abroad. The quality of these products is not known, and they may not be protective and may be dangerous. These medications may have been produced by substandard manufacturing practices, may be counterfeit, or may contain contaminants. Additional information on this topic can be found in an FDA document

Purchasing Medications Outside the United States

    .

 

Community Based Management for Malaria

by

QUESTION

what are the methods for community based management for malaria?

ANSWER

Community-based management of malaria revolves around three main principles: prevention, diagnosis and treatment.

Prevention mainly revolves around stopping mosquitoes from biting people. Methods for this include distribution of long-lasting insecticide treated bednets (and teaching people to use them properly!), indoor residual spraying to stop mosquitoes from living in houses, screening houses properly and removing sources of stagnant water from the community to stop mosquitoes from breeding. Collectively, these methods are considered “vector control”. They have benefit for the individuals who practice the methods, as well as collective benefit at the community level from reduced transmission. Within the community, pregnant women and young children, who are most at risk of severe infection, are often targeted for preventive measures. In addition, transmission of malaria from a pregnant mother to her unborn child can be prevented through chemoprophylaxis, administered usually twice during pregnancy, in a process known as intermittent preventive therapy (IPT).

Diagnosis and treatment involves educating people about the symptoms of malaria so that if they suspect they are infected, they know how and where to seek appropriate medical care. The community therefore has to provide a clinic or hospital that is sufficiently equipped to do accurate diagnosis, which requires blood testing. Clinicians should also be able to identify which type of malaria the patient is infected with, since this determines treatment. Identification of the type of malaria is usually done via looking at the blood of the patient under a microscope, a process which requires a significant amount of training. The type of treatment depends on the severity of infection as well as the type of parasite they are infected with.

All of the above interventions depend on sustained investment in community health care, training of local health workers and clinicians and education the community about the transmission of malaria and how this can be interrupted.

Free Medical Care for Malaria

by

QUESTION

Can you get free medical help for someone In Nigeria that has malaria?

ANSWER

Theoretically, the Nigerian government should provide basic services, including malaria diagnosis, through primary care clinics which are administered by local government. In addition, Nigeria has recently instituted a National Health Insurance program, which again should assist in providing health care to many sectors of the population. However, in practice, public health care in Nigeria is still hugely underfunded and not very comprehensive—the World Health Organization (WHO) recently ranked it 187 out of 191 country health systems worldwide!

As such, I would be wary of the quality and accuracy of malaria diagnosis and treatment if you obtained it for free in Nigeria—while you might get perfectly decent care, the statistics suggest the chances of this are slim. You would probably be better off looking for a private clinic, where I imagine the cost will still be quite reasonable (especially if you are part of the National Insurance program there) and the quality of care might be more reliable. Having said this, I have no personal direct experience with health care in Nigeria, public or private, so if other readers of this site have other information, please share it in the comments section below.

Is Malaria Contagious Between Humans?

by

QUESTION

If someone has malaria, is it contagious?

ANSWER

No. Malaria cannot be transmitted via touching or saliva or air. In virtually all cases, it is only transmitted by the bite of an infected mosquito, and so cannot be passed from one person to another. There are a few exception—because the parasite lives in certain organs and in the blood, it can sometimes be transmitted via blood transfusion or organ transplant. It can also pass via the placenta from a mother to her unborn child, or to the child during childbirth.